SERAC LIFE SCIENCES LTD
Company number 11074235 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£17,684,109
Balance sheet as at 2025-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2017-11-21
- Employees
- 5 (2025 accounts)
- Registered office
- 6th Floor Charlotte Building, 17 Gresse Street, London, United Kingdom, W1T 1QL
- Postcode
- W1T 1QL
- Capital
- 72 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-11-20
- Next due by
- 2026-12-04
Nature of business (SIC)
- 64209 Activities of other holding companies not elsewhere classified
Officers 4 current · 1 resigned
Group structure 3 subsidiaries
From persons-with-significant-control filings on the public register.
Contact details
- Website
- seraclifesciences.com
Through its two wholly owned subsidiaries, Serac Life Sciences is developing two late-stage molecular imaging technologies
Among its peers
Top 5%
by shareholders' funds, of 3,079 similar companies in W
Among the biggest employers among its local peers (5 staff).
Among the oldest 25% of its local peers, trading since 2017.
Competitors London
This company ranks 137 among activities of other holding companies not elsewhere classified in London.
The class of 2017
59%
of the 6,516 companies in this sector incorporated in 2017 are still active today; 38% have since been dissolved.
A fact about the year, not a forecast for this company.